RETA
Price:
$172.36
Market Cap:
$6.57B
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney disease (CKD) caused by Alport syndrome, as well as for a form of pulmonary arterial hypertension associated with connective tissue disease; omaveloxolone that is Phase II clinical trial to treat Friedreich's ataxia; and conduct Phase 2 study for various form of CKD, such as IgA nephropathy, type 1 and type 2 diabetic CKD, hypertensive CKD, focal segmental ...[Read more]
Industry
Biotechnology
IPO Date
2016-05-26
Stock Exchange
NASDAQ
Ticker
RETA
According to Reata Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 6.68B. This represents a change of 161.45% compared to the average of 2.56B of the last 4 quarters.
The mean historical Enterprise Value of Reata Pharmaceuticals, Inc. over the last ten years is 1.31B. The current 6.68B Enterprise Value has changed 50.77% with respect to the historical average. Over the past ten years (40 quarters), RETA's Enterprise Value was at its highest in in the December 2019 quarter at 5.96B. The Enterprise Value was at its lowest in in the December 2014 quarter at -15873000.00.
Average
1.31B
Median
535.60M
Minimum
-104642000.00
Maximum
5.71B
Discovering the peaks and valleys of Reata Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.06%
Maximum Annual Enterprise Value = 5.71B
Minimum Annual Increase = -288.23%
Minimum Annual Enterprise Value = -104642000.00
Year | Enterprise Value | Change |
---|---|---|
2022 | 1.46B | 189.33% |
2021 | 503.57M | -84.96% |
2020 | 3.35B | -41.33% |
2019 | 5.71B | 340.62% |
2018 | 1.30B | 128.23% |
2017 | 567.63M | 63.17% |
2016 | 347.87M | 1.06% |
2015 | 29.88M | -288.23% |
2014 | -15873000.00 | -84.83% |
The current Enterprise Value of Reata Pharmaceuticals, Inc. (RETA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
1.77B
5-year avg
2.46B
10-year avg
1.31B
Reata Pharmaceuticals, Inc.’s Enterprise Value is less than Sarepta Therapeutics, Inc. (13.28B), greater than Mirati Therapeutics, Inc. (3.91B), greater than Krystal Biotech, Inc. (4.95B), greater than Intercept Pharmaceuticals, Inc. (915.81M), less than PTC Therapeutics, Inc. (0), greater than Madrigal Pharmaceuticals, Inc. (2.17B), greater than CureVac N.V. (4.91B), greater than Vir Biotechnology, Inc. (390.67M), greater than Propanc Biopharma, Inc. (864.03M), greater than Viking Therapeutics, Inc. (1.07M), greater than Terns Pharmaceuticals, Inc. (5.95B), greater than Akero Therapeutics, Inc. (458.36M), greater than null (1.56B),
Company | Enterprise Value | Market cap |
---|---|---|
13.28B | $12.29B | |
3.91B | $4.12B | |
4.95B | $5.29B | |
915.81M | $794.69M | |
0 | $2.43B | |
2.17B | $5.30B | |
4.91B | $614.60M | |
390.67M | $1.06B | |
864.03M | $278.87K | |
1.07M | $6.00B | |
5.95B | $549.60M | |
458.36M | $1.83B | |
1.56B | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Reata Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Reata Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Reata Pharmaceuticals, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Reata Pharmaceuticals, Inc. (RETA)?
What is the 3-year average Enterprise Value for Reata Pharmaceuticals, Inc. (RETA)?
What is the 5-year average Enterprise Value for Reata Pharmaceuticals, Inc. (RETA)?
How does the current Enterprise Value for Reata Pharmaceuticals, Inc. (RETA) compare to its historical average?